Boston Scientific (NYSE:BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment. As a strategic investor in SoniVie, Boston Scientific currently holds an equity ...

March 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company ...

Boston Scientific (NYSE: BSX) is buying into the business of acquisitions. The Marlborough medical device firm has announced its second acquisition thus far in 2025. Boston Scientific Corp. has ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire SoniVie, a privately held medical device company that has developed the Tivus Intravascular Ultrasound System.

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ultrasound-based therapy for stubbornly high blood pressure. The acquisition sets up ...

MARLBOROUGH, Mass., Feb. 26, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V ...

Boston Scientific has agreed to buy the rest of privately held medical-device company SoniVie for an initial $360 million in a deal that expands its portfolio of interventional cardiology therapies.

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.

Nvidia, the world's most valuable chipmaker, is coming to Boston. The Santa Clara, Calif.-based company said Tuesday it will ...

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the November 21st expiration. One of the key inputs that goes into the price an option buyer is willing ...